sellWeak
Walgreens Boots Alliance, Inc. sold $315M of COR
owner at Cencora, Inc.. 1,286,376 shares at an average of $244.51, traded Feb 6, 2025, filed Feb 10, 2025.
Warning score
37Value
$315M
1,286,376 shares
Holdings after
12,570,000
-6% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-25-017321, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 6, 2025 | SOpen-market sale Common Stockindirect: See footnotes | -1,081,885 | $244.51 | $265M | 18,898,115 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Common Stockindirect: See footnotes | -2,159,136 | $244.51 | $528M | 16,738,979 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Common Stockindirect: See footnotes | -1,323,172 | $244.51 | $324M | 15,415,807 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Common Stockindirect: See footnotes | -436,653 | $244.51 | $107M | 14,979,154 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Common Stockindirect: See footnotes | -437,884 | $244.51 | $107M | 14,541,270 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Common Stockindirect: See footnotes | -879,015 | $244.51 | $215M | 13,662,255 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Common Stockindirect: See footnotes | -439,989 | $244.51 | $108M | 13,222,266 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Common Stockindirect: See footnotes | -447,775 | $244.51 | $109M | 12,774,491 | Feb 10, 2025 |
| Feb 6, 2025 | SOpen-market sale Common Stockindirect: See footnotes | -204,491 | $244.51 | $50M | 12,570,000 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Forward sale contract (obligation to sell)derivativeindirect: See footnotes | -2,625,000 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Forward sale contract (obligation to sell)derivativeindirect: See footnotes | -1,575,000 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Forward sale contract (obligation to sell)derivativeindirect: See footnotes | -525,000 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Forward sale contract (obligation to sell)derivativeindirect: See footnotes | -525,000 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Forward sale contract (obligation to sell)derivativeindirect: See footnotes | -1,080,000 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Forward sale contract (obligation to sell)derivativeindirect: See footnotes | -540,000 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Feb 6, 2025 | JOther Forward sale contract (obligation to sell)derivativeindirect: See footnotes | -540,000 | $0.00 | $0 | 0 | Feb 10, 2025 |
Related signals
Other insiders at Cencora, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 25Weak | sell 310b5-1 | COR Cencora, Inc. | COLLIS STEVEN H Executive Chairman | $3.9M | 14,578 | |
| 40Moderate | sell 410b5-1 | COR Cencora, Inc. | Campbell Elizabeth S Executive Vice President | $1.1M | 4,127 | |
| 30Weak | sell 410b5-1 | COR Cencora, Inc. | Mauch Robert P. President & CEO | $1.3M | 4,970 | |
| 48Moderate | sell 4 | COR Cencora, Inc. | Krikorian Lazarus SVP & Chief Accounting Officer | $520k | 2,000 | |
| 30Weak | sell 410b5-1 | COR Cencora, Inc. | Mauch Robert P. President & CEO | $1.3M | 4,970 | |
| 25Weak | sell 410b5-1 | COR Cencora, Inc. | COLLIS STEVEN H Executive Chairman | $3.7M | 14,579 | |
| 60Notable | sell 3 | COR Cencora, Inc. | Battaglia Silvana Executive Vice President | $1.2M | 5,000 | |
| 31Weak | sell | COR Cencora, Inc. | Battaglia Silvana Executive Vice President | $384k | 1,678 | |
| 40Moderate | sell 2 | COR Cencora, Inc. | Krikorian Lazarus SVP & Chief Accounting Officer | $455k | 1,816 | |
| 58Moderate | sell 2 | COR Cencora, Inc. | COLLIS STEVEN H Executive Chairman | $12M | 50,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.